InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2023-06-14 00:00:00 ET · period of report 2023-06-13 · accession 0001104659-23-071286 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-14 2023-06-13 AMPH Zhou Rong EVP, Production Center S - Sale+OE $48.24 -5,000 88.3K -5% -$241.2K
D 2023-06-14 2023-06-13 AMPH Zhou Rong EVP, Production Center M - OptEx $14.40 +5,000 93.3K +6% +$72.0K
D 2023-06-14 2023-06-13 AMPH Zhou Rong EVP, Production Center M - OptEx $0.00 -5,000 17.9K -22% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-13 S D 5,000 $48.24 88,313 D — —
2 Common Common Stock 2023-06-13 M A 5,000 $14.40 93,313 D — — (F1) Includes 715 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2023.
3 Derivative Employee Stock Option (right to buy) 2023-06-13 M D 5,000 $0.00 17,891 D $14.40 · — to 2024-04-14 5,000 Common Stock (F4) Shares subject to the option are fully vested and immediately exercisable.